Study finds weakness in drug-resistant tuberculosis pathogens

A University of Otago-led study has found highly vulnerable weakness in drug-resistant Mycobacterium tuberculosis, offering a new way to kill them.

Arc Institute publishes new AI model Evo, creating CRISPR systems in a leap for synthetic biology

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 15, 2024

Pharmalittle: We’re reading about Zepbound pricing caveats, PBM congressional testimony, and more

Rise and shine, everyone, another busy day is on the way. We can tell because the official mascots are barking at an unusually high number

August 29, 2024

Neural implants face ethical hurdles, study finds

Study delves into the ethical, design, and clinical trial challenges of AI-driven neural implants, highlighting the need for advancements in accuracy, user privacy, and societal

April 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.